Document is current
Any future updates will be listed below
-
Authors
Ughi, Nicola https://orcid.org/0000-0003-4637-1133
Bernasconi, Davide Paolo
Del Gaudio, Francesca
Dicuonzo, Armanda
Maloberti, Alessandro
Giannattasio, Cristina
Tarsia, Paolo
Travi, Giovanna
Scaglione, Francesco
Colombo, Fabrizio
Bertuzzi, Michaela
Adinolfi, Antonella
Valsecchi, Maria Grazia
Rossetti, Claudio
Epis, Oscar Massimiliano
,
-
Funding
Funding for this research was provided by:
Gilead Sciences
- License Information
-
More Information
Article History
Accepted: 30 August 2023
First Online: 22 September 2023
Declarations
:
: This project was partially funded by a Medical Grant from Gilead Sciences.
: Nicola Ughi has honoraria from Janssen and Galapagos and participated in advisory boards for Abbvie outside this work. Francesco Scaglione has received speaker’s fees from GSK, MSD, Pfizer, Amgen and participated in advisory boards for Dompè and Astellas outside this work. The other Authors declared no conflict of interests.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: The study was conducted within the protocol approved by the ethics committee Milano Area 3 (register number 249-13052020).
: All the participants signed an informed consent form.
: Not applicable.
: Not applicable.
: Study design: NU, FDG, AD; Data collection: NU, FDG, AD, MB. Data interpretation: All; manuscript writing: NU; manuscript editing: All; approval to submit: All.
